Prevalence of thyroid nodules and its association with metabolic syndrome in physical examination population of Mianyang Region
10.3969/j.issn.1006-2483.2026.03.032
- VernacularTitle:绵阳地区体检人群甲状腺结节患病情况与代谢综合征关联分析
- Author:
Yanlin PU
1
;
Haitao XU
1
;
Fang HE
1
;
Jianrong SU
2
;
Huiying ZHAO
3
;
Yaozhou JIA
1
;
Li LIU
1
Author Information
1. Health Management Center, Mianyang Central Hospital, Mianyang, Sichuan 621099 , China
2. Department of Clinical Laboratory, Mianyang Central Hospital, Mianyang, Sichuan 621099 , China
3. Department of Ultrasonography, Mianyang Central Hospital, Mianyang, Sichuan 621099 , China
- Publication Type:Journal Article
- Keywords:
Physical examination population;
Thyroid nodules;
Metabolic syndrome;
Prevalence rate
- From:
Journal of Public Health and Preventive Medicine
2026;37(3):151-154
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the prevalence of thyroid nodules in the physical examination population in Mianyang region and analyze its association with metabolic syndrome. Methods A retrospective study was conducted on 9 978 individuals who underwent health examinations at our hospital from January 2024 to May 2025. Thyroid examinations were performed using color Doppler ultrasound to analyze the prevalence of thyroid nodules in this population. Clinical data of all subjects were collected, and logistic regression analysis was employed to assess the association between metabolic syndrome and the risk of thyroid nodule development. Results The prevalence of thyroid nodules in the physical examination population of Mianyang region was 17.98% (1 794/9 978). The logistic regression results showed that after adjusting for gender, age, BMI, occupation, consumption of non-iodized salt, staying up late, daily sleep duration, anxiety, and depression, metabolic syndrome (OR=6.593, 95% CI: 3.961-10.975) was associated with thyroid nodules (P<0.05). Conclusion The prevalence of thyroid nodules among the physical examination population in the Mianyang area is 17.98%, and metabolic syndrome remains associated with the risk of thyroid nodules after effectively controlling for confounding factors.
